Spots Global Cancer Trial Database for stage ii breast cancer ajcc v6 and v7

Every month we try and update this database with for stage ii breast cancer ajcc v6 and v7 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer	NCT01266642	Ductal Breast C... Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	External Beam R... External Beam R... Hypofractionate... Laboratory Biom... Quality-of-Life... Questionnaire A... Whole Breast Ir... Whole Breast Ir...	40 Years -	M.D. Anderson Cancer Center
Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC	NCT02593175	Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-Negative...	Carboplatin Paclitaxel Panitumumab	18 Years -	M.D. Anderson Cancer Center
Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC	NCT02593175	Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-Negative...	Carboplatin Paclitaxel Panitumumab	18 Years -	M.D. Anderson Cancer Center
The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer	NCT03454529	Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Laboratory Biom... Simvastatin	19 Years -	Barbara Ann Karmanos Cancer Institute
The Role of Lifestyle Factors in Breast Cancer-Related Outcomes	NCT02079662	Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Behavioral, Psy... Best Practice Cognitive Inter... Computer-Assist... Counseling Exercise Interv... Laboratory Biom... Quality-of-Life... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence	NCT04054557	Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage III Breas...	Telemedicine Best Practice Questionnaire A... Quality-of-Life... Survey Administ... Behavioral Inte... Educational Int...	18 Years -	Thomas Jefferson University
Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer	NCT02883062	Invasive Breast... Stage II Breast... Stage III Breas... Triple-Negative...	Atezolizumab Biospecimen Col... Carboplatin Lumpectomy Mastectomy Paclitaxel	18 Years -	National Cancer Institute (NCI)
SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer	NCT03411070	Positive Axilla... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Implanted Medic... Therapeutic Con...	18 Years -	Jonsson Comprehensive Cancer Center
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative	NCT02276443	Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-Negative...	Chemotherapy Immunotherapy Laboratory Biom... Lymph Node Biop... Ultrasonography	18 Years -	M.D. Anderson Cancer Center
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer	NCT02598557	Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Exemestane Laboratory Biom... Pharmacological... Placebo Adminis... Quality-of-Life... Questionnaire A... Therapeutic Con...	- 75 Years	National Cancer Institute (NCI)
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery	NCT03317405	Breast Ductal C... Breast Lobular ... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Endoxifen Hydro... Placebo Adminis... Questionnaire A...	18 Years -	National Cancer Institute (NCI)
Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery	NCT02654119	HER2 Positive B... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Cyclophosphamid... Laboratory Biom... Paclitaxel Trastuzumab	20 Years -	University of Nebraska
Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer	NCT02883062	Invasive Breast... Stage II Breast... Stage III Breas... Triple-Negative...	Atezolizumab Biospecimen Col... Carboplatin Lumpectomy Mastectomy Paclitaxel	18 Years -	National Cancer Institute (NCI)
Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer	NCT02689427	Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-Negative...	Axillary Lymph ... Enzalutamide Laboratory Biom... Lymph Node Biop... Paclitaxel Therapeutic Con...	18 Years -	M.D. Anderson Cancer Center
Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC	NCT02593175	Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-Negative...	Carboplatin Paclitaxel Panitumumab	18 Years -	M.D. Anderson Cancer Center
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer	NCT02954874	Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage II Breast... Stage III Breas... Triple-Negative...	Biospecimen Col... Laboratory Biom... Patient Observa... Pembrolizumab Quality-of-Life... Questionnaire A... Radiation Thera...	18 Years -	National Cancer Institute (NCI)
Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors	NCT03319342	Cancer Survivor Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea...	Behavioral Inte... Behavioral Inte... Behavioral Inte... Behavioral Inte... Questionnaire A...	19 Years -	Jonsson Comprehensive Cancer Center
Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer	NCT03012100	Bilateral Breas... Breast Inflamma... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-Negative... Unilateral Brea...	Cyclophosphamid... Laboratory Biom... Multi-epitope F... Placebo Adminis... Sargramostim	18 Years -	Academic and Community Cancer Research United
The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer	NCT03454529	Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Laboratory Biom... Simvastatin	19 Years -	Barbara Ann Karmanos Cancer Institute
The Role of Lifestyle Factors in Breast Cancer-Related Outcomes	NCT02079662	Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Behavioral, Psy... Best Practice Cognitive Inter... Computer-Assist... Counseling Exercise Interv... Laboratory Biom... Quality-of-Life... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors	NCT03319342	Cancer Survivor Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea...	Behavioral Inte... Behavioral Inte... Behavioral Inte... Behavioral Inte... Questionnaire A...	19 Years -	Jonsson Comprehensive Cancer Center
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer	NCT03077841	Ductal Breast C... Early-Stage Bre... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Laboratory Biom... Partial Breast ... Questionnaire A...	50 Years -	M.D. Anderson Cancer Center
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative	NCT02276443	Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-Negative...	Chemotherapy Immunotherapy Laboratory Biom... Lymph Node Biop... Ultrasonography	18 Years -	M.D. Anderson Cancer Center
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer	NCT02598557	Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Exemestane Laboratory Biom... Pharmacological... Placebo Adminis... Quality-of-Life... Questionnaire A... Therapeutic Con...	- 75 Years	National Cancer Institute (NCI)
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer	NCT03077841	Ductal Breast C... Early-Stage Bre... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Laboratory Biom... Partial Breast ... Questionnaire A...	50 Years -	M.D. Anderson Cancer Center
Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer	NCT03568526	Peripheral Neur... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Educational Int... Exercise Interv... Quality-of-Life... Questionnaire A... Survey Administ...	-	Ohio State University Comprehensive Cancer Center
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection	NCT05334069	Acute Lymphobla... Acute Myeloid L... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Chronic Lymphoc... Chronic Myeloid... Gastroesophagea... Head and Neck C... Hematopoietic a... Invasive Breast... Kidney Carcinom... Malignant Hepat... Malignant Solid... Melanoma Muscle-Invasive... RISS Stage I Pl... RISS Stage II P... RISS Stage III ... Sarcoma Stage I Bladder... Stage I Breast ... Stage I Colorec... Stage I Esophag... Stage I Gastric... Stage I Lung Ca... Stage I Ovarian... Stage I Pancrea... Stage I Prostat... Stage I Uterine... Stage II Bladde... Stage II Breast... Stage II Colore... Stage II Esopha... Stage II Gastri... Stage II Lung C... Stage II Ovaria... Stage II Pancre... Stage II Prosta... Stage II Uterin... Stage III Bladd... Stage III Breas... Stage III Color... Stage III Esoph... Stage III Gastr... Stage III Lung ... Stage III Ovari... Stage III Pancr... Stage III Prost... Stage III Uteri... Stage IV Bladde... Stage IV Breast... Stage IV Colore... Stage IV Esopha... Stage IV Gastri... Stage IV Lung C... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Uterin... Thyroid Gland C...	Questionnaire A... Biospecimen Col...	40 Years - 75 Years	Alliance for Clinical Trials in Oncology
Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer	NCT01245712	Breast Adenocar... Ductal Breast C... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Accelerated Par... Proton Beam Rad... Quality-of-Life...	18 Years -	M.D. Anderson Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: